Ongoing and future melanoma trials

Brigitte Dréno, MD, PhD from the University Hospital of Nantes, Nantes, France discusses current and future clinical trials in melanoma at the 2016 World Congress on Cancers of the Skin (WCCS) and the Congress of the European Association of Dermato-Oncology (EADO) in Vienna, Austria. Dr Dréno talks about ongoing melanoma trials using, for example, anti-PD-l treatments, as well as oncolytic viruses combined with ipilimumab or anti-PD-1. Dr Dréno also comments on future trials using adoptive T-cell therapy and chimeric antigen receptors (CAR) but notes on their many adverse effects.

Share this video